X
Xiangyang Liu
Researcher at Peking Union Medical College
Publications - 30
Citations - 354
Xiangyang Liu is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Survival rate & Esophageal cancer. The author has an hindex of 9, co-authored 30 publications receiving 272 citations.
Papers
More filters
Journal ArticleDOI
A retrospective study of unicentric and multicentric Castleman’s disease: a report of 52 patients
Bo Ye,Shu-Geng Gao,Wang Li,Long-Hai Yang,Shou-Hua Zhao,Ke Ma,Xiao-Lei Zhu,Xiangyang Liu,Ke-Ling Sun +8 more
TL;DR: 52 patients with Unicentric Castleman’s disease (UCD) and Multicentric Castle manx disease (MCD) treated from 1999–2008 at a single institution are examined in hopes of providing a better understanding of this rare disease.
Journal ArticleDOI
Epidermal growth factor receptor is a prognosis predictor in patients with esophageal squamous cell carcinoma.
Wencheng Zhang,Wencheng Zhang,Hongxia Zhu,Xiao Liu,Qifeng Wang,Xun Zhang,Jie He,Kelin Sun,Xiangyang Liu,Zongmei Zhou,Ningzhi Xu,Zefen Xiao +11 more
TL;DR: Expression of EGFR can be a prognostic predictor for ESCC and patients with high expression of EG FR may benefit from postoperative radiation therapy.
Journal ArticleDOI
The Impact of Postoperative Conformal Radiotherapy after Radical Surgery on Survival and Recurrence in Pathologic T3N0M0 Esophageal Carcinoma: A Propensity Score-Matched Analysis
Jinsong Yang,Wencheng Zhang,Zefen Xiao,Qifeng Wang,Zongmei Zhou,Hongxing Zhang,Dongfu Chen,Q. Feng,Jie He,Shugeng Gao,Kelin Sun,Xiangyang Liu,Dekang Fang,Juwei Mu,Dali Wang,Yexiong Li +15 more
TL;DR: Postoperative radiotherapy using cRT is strongly associated with improved OS and DFS in patients with pT3N0M0 TESCC and a multicenter, randomized phase III clinical trial is warranted to confirm these findings.
Journal ArticleDOI
Postoperative intensity-modulated radiotherapy improved survival in lymph node-positive or stage III thoracic esophageal squamous cell carcinoma.
Wencheng Zhang,Xiao Liu,Zefen Xiao,Hongxing Zhang,Dongfu Chen,Qinfu Feng,Zongmei Zhou,Jima Lv,Jun Liang,Zhouguang Hui,Lvhua Wang,Weibo Yin,Gui-yu Cheng,Kelin Sun,Xiangyang Liu,Dekang Fang,Jie He +16 more
TL;DR: Postoperative IMRT reduces local recurrence and improves survival in lymph node-positive or stage III thoracic esophageal squamous cell carcinoma patients, providing a rationale for selection criteria for postoperative IM RT in TESCC.
Journal ArticleDOI
Nomogram to Predict Overall Survival for Thoracic Esophageal Squamous Cell Carcinoma Patients After Radical Esophagectomy
Wei Deng,Wencheng Zhang,Jinsong Yang,Wenjie Ni,Shufei Yu,Chen Li,Xiao Chang,Zongmei Zhou,Dongfu Chen,Qinfu Feng,Xiaohui Chen,Yu Lin,Kunshou Zhu,Xiongwei Zheng,Jie He,Shugeng Gao,Qi Xue,Yousheng Mao,Gui-yu Cheng,Kelin Sun,Xiangyang Liu,Dekang Fang,Junqiang Chen,Zefen Xiao +23 more
TL;DR: The nomogram could effectively predict OS and aided decision making in adjuvant therapy for patients with thoracic esophageal squamous cell carcinoma after esophagectomy and showed favorable prognostic efficacy in the training and validation cohorts.